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Purpose: To investigate the associations between assisted reproductive technology (ART) and 
severe retinopathy of prematurity (ROP) requiring treatment. 
Methods: Retrospective analyses of inborn preterm infants screened for severe ROP at the Weill 
Cornell Medical Center Neonatal Intensive Care Unit at the New York-Presbyterian Hospital 
by single factor logistic regression and multifactor models.
Results: Of 399 ethnically diverse infants, 253 were conceived naturally and 146 by ART. 
Eight (3.16%) patients conceived naturally, and 11 (7.53%) with ART required laser treatment. 
In multifactor analyses, significant risks for severe ROP requiring treatment included both 
gestational age (odds ratio [OR] 0.34; 95% confidence interval [CI] 0.23–0.52; P , 0.001) and 
ART ([OR] 4.70; [CI], 1.52–4.57; P = 0.007).
Conclusions: ART is associated with severe ROP requiring treatment in this cohort. This is 
the first report that demonstrates a statistically significant association between ART and severe 
ROP requiring treatment in infants in the US.
Keywords: retinopathy of prematurity, low birth rate, blindness, assisted reproductive 
technology
Introduction
Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the developing 
retina that accounts for over 50,000 blind children worldwide. In the US, severe 
ROP is a major cause of childhood blindness and is the leading cause of blindness in 
premature babies.1–3
Historically, two epidemics of severe ROP have been described in industrialized 
countries. The first occurred in the 1940s and 1950s and was largely attributed to unmoni-
tored, supplemental oxygen at birth. Technologic advances permitting the regulation 
and monitoring of oxygen led to a reduction in the incidence of ROP. A second rise in 
acute ROP occurred in the 1970s in association with improved survival of premature 
infants born at young gestational ages and low birth weights.3 With ongoing advances in 
neonatal care, there has been an increase in the survival of extremely low birth weight 
infants (less than 1000 g).3,4 Also, preterm birth is on the rise in many regions in the US 
and worldwide. These factors add to the likelihood of increased incidence of ROP.
Both the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) and the Early 
Treatment for Retinopathy of Prematurity (ET-ROP) studies provided an understanding 
of the natural history of ROP and evidence that treatment of the peripheral avascular 
retina in severe forms of ROP was associated with better anatomic and functional 
results.5,6 However, despite appropriate and timely management, ROP still causes Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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visual impairment and blindness in many infants in the US, 
particularly those born at extremely low birth weights.7
Prematurity and very low birth weight have been linked 
to assisted reproductive technology (ART), partly because of 
multiple births. In the US, the number of babies conceived 
through ART is increasing.8 Reports of the impact of ART on the 
incidence or progression of ROP have been inconsistent in the 
past. Some studies found associations between ART and ROP, 
whereas more recent studies suggest that ART alone was not 
associated with ROP, but rather that other known risk factors, 
such as young gestational age, low birth weight, or multiple 
births, possibly accounted for some of the previously reported 
associations.9–13 Given the lack of consistency in the published 
data, and specifically because previous studies had not been 
reported in patient samples in the US, we were interested in 
the role of ART in the development of severe ROP. Therefore, 
we explored associations between ART and ROP requiring 
treatment in a single neonatal intensive care setting.
Methods
subjects
Institutional review board approval was obtained to perform 
a retrospective review of consecutive inborn infants at the 
Weill Cornell Medical Center Neonatal Intensive Care Unit 
at the New York-Presbyterian Hospital from June 2002 to 
August 2007. The screening criteria at Weill Cornell   Medical 
Center Neonatal Intensive Care Unit for ROP during the 
time of this study were gestational age ,32 weeks and/or 
birth weight ,1500 g, with first examinations at 31 weeks 
postgestational age or 4–6 weeks after birth. Also included in 
screening beyond these criteria were infants on high oxygen 
who had unstable courses in the Neonatal Intensive Care Unit 
or for whom a consultation was requested by a neonatologist. 
Infants were divided into two groups, ie, those conceived 
naturally (natural conception group) or by ART. Infants were 
also stratified into those born at birth weights ,1000 g and 
those born at 1000–1500 g. Included in the review were all 
patients born within Weill Cornell Medical Center, without 
pre-existing congenital disorders, and who had survived 
throughout the hospital stay. White race has been found to 
be an independent risk factor for developing severe ROP,14–17 
and efforts were made to recruit all ethnicities and races. 
Information abstracted from records included birth weight, 
gestational age, gender, race, type of pregnancy, complications 
of prematurity, ventilation, and duration of oxygen exposure. 
Zone and stage of ROP were documented in accordance with 
the International   Classification for ROP.18 Examinations were 
performed by one of two examiners (RVPC and TCL).
statistical analysis
Statistical analyses were performed using SAS 9.0 (SAS Insti-
tute, Cary, NC). Initially, single factor logistic regression was 
performed on all risk factors (see Table 1) individually to test 
their association with ROP needing laser treatment. A multi-
factor model was then constructed using risk factors that were 
suggestive of association with need for laser treatment, defined 
as P , 0.1 in the single factor analysis. In order to create the 
most parsimonious statistical model predictive of the need 
for laser treatment of ROP, a second multifactor model was 
constructed using risk factors that remained significant after 
the initial multifactor model, as performed in previous epide-
miologic papers.19 The Students’ t-test was used to determine if 
there was a significant difference in mean birth weight between 
the natural conception and ART groups, and the Mann–Whitney 
U test was used to analyze mean gestational ages between 
infants requiring laser in the two groups. A P value of #0.05 
was considered statistically significant. Tests for interactions 
between variables were also performed in SAS.20
Results
study population
The patient population comprised 399 infants, of whom 47 
were black, 252 white, 50 Hispanic, 39 Asian, five Native 
American, and six infants of other races. Of these 399 infants, 
253 were in the natural conception group and 146 were in the 
ART group. Of the infants born through natural conception, 
38 were black, 133 white, 44 Hispanic, 32 Asian, two Native 
American, and four infants of other races. Of those naturally 
conceived, 128 were male and 125 female, and there were 157 
(62%) singletons and 96 (38%) multiplets. Mean gestational 
age at birth was 29.00 ± 2.14 weeks. In the ART group, nine 
infants were black, 119 white, six Hispanic, seven Asian, three 
Native American, and two infants of other race. Of infants in 
the ART group, 81 (55%) were male and 65 (45%) female, 
and there were 18 (12%) singletons and 128 (88%) multiplets. 
Mean gestational age was 29.14 ± 2.00 weeks (Table 1).
The mean birth weight for all 399 infants was 
1207.5 ± 351.1 g. There was a significant difference 
between mean birth weight of infants in the natural con-
ception group compared with those in the ART group 
(1255.8 ± 362.2 g and 1179.6 ± 342.1 g, respectively, 
P = 0.04, Table 2).
risk of rOP requiring treatment
Eight (3.16%) of 253 infants in the natural conception group 
and 11 (7.53%) of 146 infants in the ART group developed 
severe ROP that required laser treatment. Of the 19 infants Clinical Ophthalmology 2010:4
Table 1 Patient characteristics
All Natural conception ART
Total patients 399 (100.00%) 253 (63.41%) 146 (36.59%)
Mean BW in grams (sD) 1207.47 (351.07) 1179.57 (342.14) 1255.81 (362.16)
Mean gA in weeks (sD) 29 1/7 (2 1/7) 29 (2 1/7) 29 1/7 (2)
Gender
Male 209 (52.38%) 128 (50.59%) 81 (55.48%)
Female 190 (47.62%) 125 (49.41%) 65 (44.52%)
Race
Black 47 (11.78%) 38 (15.02%) 9 (6.16%)
White 252 (63.16%) 133 (52.57%) 119 (79.87%)
hispanic 50 (12.53%) 44 (17.39%) 6 (4.03%)
Asian 39 (9.77%) 32 (12.65%) 7 (4.70%)
native American 5 (1.25%) 2 (0.79%) 3 (2.01%)
Other 6 (1.50%) 4 (1.58%) 2 (1.34%)
Unknown 0 (0.00%) 0 (0.00%) 0 (0.00%)
Multiple births
singleton 175 (43.86%) 157 (62.06%) 18 (12.33%)
Multiplets 224 (56.14%) 96 (37.94%) 128 (87.67%)
Twins 188 (47.12%) 92 (36.36%) 96 (65.75%)
Triplets 32 (8.02%) 4 (1.58%) 28 (19.18%)
Quadruplets 4 (1.00%) 0 (0.00%) 4 (2.74%)
Mean MA in years (sD) 33.21 (6.00) 31.9 (5.57) 35.46 (6.00)
Details of ROP treatment
Lasered 19 (4.76%) 8 (3.16%) 11 (7.53%)
Post-gA at laser in weeks 36 35 4/7 36 2/7
Complications
MV 134 (33.58%) 84 (33.20%) 50 (34.25%)
sepsis 77 (19.30%) 53 (20.95%) 24 (16.44%)
iVh 59 (14.79%) 42 (16.60%) 17 (11.64%)
BPD 17 (4.26%) 13 (5.14%) 4 (2.74%)
neC 18 (4.51%) 13 (5.14%) 5 (3.42%)
Abbreviations: ART, assisted reproductive technology; GA, gestational age; BW, birth weight; SD, standard deviation; MA, maternal age; MV, mechanical ventilation defined 
as $96 hours; iVh, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; neC, necrotizing enterocolitis; rOP, retinopathy of prematurity.
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Table 2 Differences in characteristics of infants born by assisted reproductive technology and natural conception
Category ART Natural conception t-test P valuea
Mean BW in grams (sD) 1255.81 (362.16) 1179.57 (342.14) 0.04
BW in lasered children in grams (sD) 780.00 (130.09) 757.13 (147.37) 0.72
Mean age for laser in weeks (sD) 36.26 (2.17) 35.54 (3.05) 0.56
Note: astudents’ t-test was used to determine if there was a significant difference between the two values. 
Abbreviations: ArT, assisted reproductive technology; BW, birth weight; sD, standard deviation.
who required laser treatment, 7 (37%) were singletons and 
12 (63%) were multiplets. In the natural conception group, 
four (50%) of eight infants treated with laser were singletons 
and four (50%) were multiplets (all twins). In the ART group, 
three (27%) were singletons, and eight (73%) were multiplets 
(six twins and two triplets). In single factor analysis, ART 
was a modest risk factor for requiring laser treatment for ROP 
when compared with natural conception (P = 0.06, Table 3). 
When the subject population included only those infants 
born under 1500 g and was stratified by birth weight, ART 
was found to be a significant factor associated with severe 
ROP requiring treatment, particularly for those infants born 
less than 1000 g (odds ratio [OR] 3.57; confidence interval 
[CI] 1.24–10.25; P = 0.02, Table 4). Table 3 also shows that 
birth weight, mechanical ventilation $96 hours, sepsis, or 
bronchopulmonary dysplasia (factors that were P # 0.1 in 
single factor analysis) when included in the initial multifac-
tor analysis (Table 3), were not statistically significant in the 
presence of the other factors. In an initial multifactor model, 
gestational age, ART, and necrotizing enterocolitis remained 
significant after controlling for the effects of birth weight, 
mechanical ventilation, sepsis, and   bronchopulmonary Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Table 3 Logistic regression analysis of risk factors for retinopathy of prematurity requiring laser treatment (n = 399)
Risk factor Single factor analysis Multifactor analysis 1a Multifactor analysis 2b
OR 95% CI P value Adj OR 95% CI P value Adj OR 95% CI P value
gA 0.38 0.26–0.54 ,0.001 0.42 0.23–0.78 0.003 0.34 0.23–0.52 0.001
BW 0.99 0.991–0.996 ,0.001 1.00 0.99–1.00 0.19 – – –
ArT 2.50 0.98–6.35 0.06 5.55 1.63–18.83 0.006 4.70 1.52–14.57 0.007
Female gender 0.79 0.31–2.01 0.62 – – – – – –
singleton 0.74 0.28–1.91 0.53 – – – – – –
Maternal age 1.03 0.96–1.11 0.43 – – – – – –
MV 8.19 2.66–25.21 ,0.001 0.92 0.21–3.98 0.91 – – –
sepsis 2.58 0.98–6.78 0.06 0.50 0.14–1.72 0.27 – – –
iVh 1.58 0.50–4.92 0.43 – – – – – –
BPD 4.90 1.30–18.79 0.02 2.53 0.47–13.49 0.27 – – –
neC 4.56 1.20–17.37 0.03 6.25 1.06–36.69 0.04 5.23 0.92–29.80 0.06
Notes: aMultivariate model was constructed using risk factors that were at least moderately associated with need for laser treatment, defined as P , 0.1 in the univariate 
analysis; bSecond multivariate model was constructed by using risk factors that remained significant in the first multivariate model. 
Abbreviations: OR, odds ratio; CI, confidence interval; Adj, adjusted; GA, gestational age; BW, birth weight; ART, assisted reproductive technology; MV, mechanical 
ventilation defined as $96 hours; iVh, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; neC, necrotizing enterocolitis.
Table 4 Single factor logistic regression analysis of risk factors for retinopathy of prematurity requiring laser treatment, stratified by 
birth weight
Risk factor BW , 1000 g (n = 112) BW , 1500 g (n = 312)
OR 95% CI P value OR 95% CI P value
gA 0.45 0.28–0.73 0.001 0.388 2.67–0.57 ,0.001
ArT 3.57 1.24–10.25 0.02 2.74 1.07–7.02 0.04
Female gender 0.37 0.13–1.04 0.06 0.74 0.29–1.90 0.53
singleton 0.35 0.12–1.02 0.05 0.63 0.24–1.64 0.35
Maternal age 1.02 0.93–1.12 0.66 1.04 0.96–1.13 0.35
MV 4.58 1.24–16.87 0.02 6.48 2.09–20.04 0.001
sepsis 0.95 0.32–2.77 0.92 1.96 0.74–5.17 0.17
iVh 0.70 0.21–2.32 0.56 1.34 0.42–4.17 0.63
BPD 2.04 0.50–8.31 0.32 4.04 1.04–15.62 0.04
neC 3.54 0.79–15.76 0.10 4.04 1.04–15.62 0.04
Abbreviations: BW, birth weight; OR, odds ratio; CI, confidence interval; GA, gestational age; ART, assisted reproductive technology; MV, mechanical ventilation defined 
as $96 hours; iVh, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; neC, necrotizing enterocolitis.
dysplasia. However, in a more stringent multifactor model 
including only ART, necrotizing enterocolitis, and gesta-
tional age, both gestational age and ART were significantly 
associated with severe ROP needing treatment (OR 0.34, 
CI 0.23–0.52; P , 0.001; and OR 4.70, CI 1.52–14.57; 
P = 0.007, respectively). To test for interaction between 
ART and birth weight, an interaction term was included in 
the model with gestational age and ART. The logistic regres-
sion showed no interaction between ART and gestational age 
(P = 0.45), suggesting that both are independent risk factors 
for severe ROP (data not shown).
Discussion
The aim of this study was to explore associations between 
ART and severe ROP requiring treatment. Using multifactor 
analysis, the key finding was that, regardless of birth weight, 
ART was associated with a nearly five-fold increased risk 
of severe ROP requiring treatment after controlling for 
potential confounders (OR 4.70, CI 1.52–14.57; P = 0.007). 
Gestational age was also a significant risk factor, and both 
gestational age and ART appear to be independent risk factors 
associated with risk of severe ROP requiring laser.
Previous studies have reported conflicting results regarding 
the relationship between ART and severe ROP. For example, 
Friling et al failed to demonstrate an association between the 
two,13 whereas Watts and Adams found an association between 
the development of threshold severe ROP and ART, specifically 
in vitro fertilization, although statistical significance was not 
achieved.11 Watts and Adams noted that for infants developing 
Stage 3 severe ROP, those conceived through in vitro fertil-
ization were born at older gestational ages on average and at 
heavier birth weights than infants who received other forms Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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of ART.11 Minasion and Fielder also reported that severe ROP 
can affect larger and more mature babies conceived through 
in vitro fertilization compared with those who are not.10 We 
observed a modestly significant increase in mean birth weight 
for infants born through ART than those through natural 
conception (P = 0.04). Although the mean gestational age at 
birth was similar between the two groups, the mean time of 
treatment for severe ROP was approximately one week later in 
the ART group (36 2/7 weeks) than in the natural conception 
group (35 4/7 weeks). Both of these findings, along with the 
lack of a significant interaction between ART and gestational 
age, suggest that a subset of infants born through ART is sus-
ceptible to severe ROP regardless of the effect of gestational 
age, postgestational age, or birth weight. These differences in 
weight and gestational age between babies requiring treatment 
for severe ROP in the ART and natural conception groups 
may also have implications for screening criteria. Although 
the CRYO-ROP study provided information on the natural 
history of infants having severe ROP,5 the natural history of 
severe ROP for infants born through ART may follow a dif-
ferent course.
ART has been associated with multiple births,21 as has 
severe ROP. In the US, the number of multiple births has 
risen dramatically over the past two decades, and much of 
this trend has been attributed to the increased use of ART.8,21 
In our study, there was a larger number of multiplets in the 
ART group, and it was the multiplets who required laser more 
often. The numbers of infants requiring laser treatment in each 
group was small (n = 8 versus n = 11), and we cannot conclude 
that multiple births was not a factor if a larger sample were 
studied.21–23 However, there are conflicting reports in the litera-
ture. Some reports have noted an increase in threshold severe 
ROP with multiple births, while others have not. Blumenfeld 
et al reported no significant difference in severe ROP incidence 
between singleton and multiple gestation babies.24 However, 
Friling et al found a trend that singletons had more severe 
ROP than multiplets, but after logistic regression analysis, the 
factors of low birth weight and gestational age were found to 
be the primary risk factors for severe ROP.13
Schaffer et al analyzed the CRYO-ROP study population 
and reported an increased risk of threshold severe ROP in 
infants born with low birth weight, young gestational age, 
white race, and of multiple births.16 Given that the majority 
of infants born through ART in the US are white,25–27 the 
racial disparity may influence the results when analyzing 
the risk of ART on severe ROP. Previous studies that exam-
ined the association between severe ROP and ART failed to 
include race as a major consideration, although infants who 
develop severe ROP are more often white than black.9–13 In 
our population, the number of black infants in the ART group 
was too small to derive meaningful conclusions, although 
when tested as a risk factor, black race was not significant 
(P = 0.96, data not shown). Furthermore, no black babies 
required laser treatment. The failure to control for race may 
cause a systematic bias, because racial differences have been 
noted in the incidence of severe ROP among infants ,1251 g 
at birth,14–17 however, black race was not significant in this 
study. Regardless, the conclusions drawn from our study 
should only be applied to nonblack infants due to the fact that 
no black infants required laser treatment in this study.
Several factors should also be considered when interpret-
ing the results of this study. First, given the retrospective 
nature of this study, our analysis was limited in controlling for 
potential confounders. We collected data on the presence of 
sepsis, mechanical ventilation time $96 hours, intraventricular 
hemorrhage, bronchopulmonary dysplasia, and necrotizing 
enterocolitis. Multifactor logistic regression analysis was 
then performed to control for the effects of these potential 
confounders with development of advanced severe ROP 
requiring treatment. Second, we were unable to look at specific 
maternal records in depth, and as a result we were unable to 
determine the type of assisted conception used or determine 
whether potential confounding risks were present, such as pre-
eclampsia or new-onset maternal gestational hypertension.28 
Watts and Adams had previously addressed this issue, stating 
that in vitro fertilization specifically was directly related to an 
increased risk of severe ROP.11 It has also been suggested that 
in vitro fertilization is associated with ocular disorders, such 
as retinoblastoma29 and that ART may predispose children 
to certain genetic abnormalities.30 Previously, 70% of the 
genetic variance in severe ROP has been reportedly attributed 
to genetic factors.31 Therefore, an association between ART 
and severe ROP may point to a genetic predisposition in these 
infants and warrant additional study. At this point, the ques-
tion remains as to whether ART predisposes infants to specific 
ocular abnormalities. Future studies should be prospective and 
investigate the type of ART methods used, the number of treat-
ments, and other fertility drugs given to the mother.
In conclusion, the data presented here suggest an associa-
tion between an ART population and severe ROP requiring 
treatment in nonblack infants. To the best of the authors’ 
knowledge, this is the first study that has found a statisti-
cally significant association between ART and severe ROP 
requiring treatment in the US. The causes for this associa-
tion, however, are unclear, and future studies are warranted 
to examine factors associated with ART.Clinical Ophthalmology
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